💊 Supplement Guide

Boswellia serrata (Indian Frankincense)

Boswellia serrata is a resin extract from the Indian frankincense tree, standardized for boswellic acids — most notably AKBA (3-O-acetyl-11-keto-β-boswellic acid). It works primarily by inhibiting 5-lipoxygenase and microsomal prostaglandin E synthase-1, dampening inflammatory leukotriene production without the gastric damage typical of NSAIDs. It's best evidenced for osteoarthritis pain and joint function, with emerging data in inflammatory bowel disease and asthma.

🩺 Health Topics
HomeSupplementsBoswellia serrata (Indian Frankincense)
⭐ Top 5 Health Benefits
Evidence-based benefits of taking Boswellia serrata (Indian Frankincense)
Multiple randomized controlled trials and meta-analyses show standardized Boswellia extracts (especially 5-Loxin and Aflapin) significantly reduce WOMAC pain and stiffness scores in knee osteoarthritis, often within 5-7 days. Evidence here is moderate-to-strong, with effect sizes comparable to low-dose NSAIDs in some trials.
Beyond pain relief, trials report measurable gains in walking distance, joint flexion, and functional capacity in osteoarthritis patients over 30-90 days. This is thought to reflect reduced cartilage degradation via inhibition of matrix metalloproteinase-3. Evidence is moderate.
Boswellic acids are among the few well-characterized natural 5-LOX inhibitors, reducing leukotriene B4 — a pathway NSAIDs do not touch. This gives it a distinct mechanism and explains its use where COX inhibition alone is insufficient. Mechanistic evidence is strong; clinical translation varies by condition.
Small trials in ulcerative colitis and collagenous colitis suggest Boswellia gum resin may be comparable to mesalazine for remission maintenance, likely via NF-κB and leukotriene suppression in the gut wall. Evidence is limited and based on small sample sizes.
A classic double-blind trial found 300 mg three times daily improved symptoms and reduced eosinophil counts in 70% of bronchial asthma patients, consistent with leukotriene inhibition (the same target as montelukast). Evidence is preliminary and needs larger replication.
🕐 How & When to Take Boswellia serrata (Indian Frankincense)
Timing, absorption tips, dosage and best form
Split doses across the day — typically 2-3 times daily with meals — since boswellic acid half-life is short (roughly 6 hours for KBA). For joint stiffness that peaks in the morning, take one dose with the evening meal. Consistent daily use for 4-8 weeks is needed to judge effect.
Take with food containing fat. Boswellic acids are highly lipophilic and poorly water-soluble; a high-fat meal can increase AKBA absorption several-fold. Taking on an empty stomach substantially reduces bioavailability.
Standard gum resin extract: 300-400 mg two to three times daily standardized to 60-65% boswellic acids. Enhanced AKBA extracts (e.g. 30% AKBA) are effective at 100-250 mg once daily. Ulcerative colitis trials used up to 1,200-1,050 mg/day of gum resin.
Standardized capsules or softgels are best; look for stated AKBA content (not just 'boswellic acids'), as AKBA is the most potent 5-LOX inhibitor. Phytosome, Aflapin or 5-Loxin formulations have superior bioavailability. Avoid unstandardized raw resin powder.
May cause mild GI upset, nausea, acid reflux or diarrhoea. It inhibits CYP3A4, CYP2C8 and CYP2C9 in vitro, so caution with narrow-therapeutic-index drugs. Avoid in pregnancy (traditionally considered emmenagogue/abortifacient) and breastfeeding. Discontinue 1-2 weeks before surgery due to possible antiplatelet effects.
🩺 May Help With These Conditions
Health conditions where Boswellia serrata (Indian Frankincense) may provide benefit
The best-supported use, with several RCTs showing reduced pain, stiffness and improved function versus placebo. Standardized extracts with 20-30% AKBA appear most effective, often with onset faster than glucosamine.
Boswellia may reduce morning stiffness and swelling as an adjunct to conventional DMARDs by suppressing leukotrienes and TNF-α. Evidence is weaker than for osteoarthritis and it should not replace disease-modifying therapy.
Small controlled trials suggest gum resin extract may induce or maintain remission comparably to mesalazine in mild-to-moderate cases. Findings are promising but underpowered; not a substitute for prescribed therapy.
By inhibiting 5-LOX, Boswellia reduces bronchoconstrictive leukotrienes, mirroring the target of leukotriene receptor antagonists. One older trial showed symptomatic benefit, but current evidence is insufficient for it to replace inhalers or controllers.
Used adjunctively for non-specific inflammatory musculoskeletal pain, sometimes combined with curcumin. Data are largely from small combination-product trials, so attribution to Boswellia alone is uncertain.
🤝 Best Taken With
Supplements that work synergistically with Boswellia serrata (Indian Frankincense)
Curcumin inhibits COX-2 and NF-κB while Boswellia targets 5-LOX, covering both major inflammatory arms. Head-to-head trials show the combination outperforms either alone in knee osteoarthritis, and it's one of the better-evidenced supplement pairings. View Curcumin (with piperine or phytosomal) guide →
Provides substrate for cartilage matrix repair while Boswellia reduces the enzymatic degradation (MMP-3) driving cartilage loss. Complementary structural plus anti-inflammatory approach; each has independent moderate evidence in osteoarthritis. View Collagen peptides (type II or hydrolysed) guide →
EPA competes with arachidonic acid as a 5-LOX substrate, producing less inflammatory leukotriene B5 — synergistic with Boswellia's direct 5-LOX inhibition. Fish oil also has independent modest evidence for joint tenderness in rheumatoid arthritis. View Omega-3 (EPA/DHA) guide →
Commonly stacked for osteoarthritis; one trial found Boswellia-containing formulas matched or exceeded glucosamine for pain relief with faster onset. Combining offers structural support alongside anti-inflammatory action, though additive benefit is not firmly proven. View Glucosamine and chondroitin sulfate guide →
Traditionally paired in Ayurvedic joint formulas; ashwagandha adds cortisol modulation and mild analgesic effects. Combination trials of Boswellia-ashwagandha-ginger blends show reduced joint pain, though individual contributions aren't separable. View Ashwagandha (Withania somnifera) guide →
💊 Similar to These Medicines
Boswellia serrata (Indian Frankincense) shares mechanisms or effects with some pharmaceutical drugs — always consult your doctor before combining supplements with medication.
Both reduce leukotriene-driven inflammation, though Boswellia inhibits 5-lipoxygenase (upstream synthesis) while montelukast blocks the CysLT1 receptor. Mechanistic overlap is well documented in vitro; clinical equivalence in asthma is not established and evidence for Boswellia here is weak.
The closest pharmacological analogue — zileuton is a direct 5-LOX inhibitor, exactly the primary target of AKBA. The mechanistic parallel is strong and well characterized, though Boswellia's potency and clinical outcome data are far less robust.
Used for the same indication — inflammatory joint pain — and some osteoarthritis trials show comparable pain reduction. Mechanisms differ (Boswellia spares COX-1 and inhibits mPGES-1 and 5-LOX instead), which is why it lacks the typical NSAID gastric and renal toxicity.
Both suppress mucosal inflammation in ulcerative colitis, partly through inhibition of leukotriene synthesis and NF-κB signalling. Small trials suggested non-inferiority of Boswellia gum resin, but the studies were underpowered and this comparison remains tentative.
⚠️ Important: Never stop or replace prescribed medication with supplements without medical supervision.
⚠️ Important Cautions
Before taking Boswellia serrata (Indian Frankincense), be aware of the following
Drug interaction potential via CYP enzymes — Boswellia inhibits several cytochrome P450 enzymes and may raise blood levels of drugs like warfarin, statins, or immunosuppressants. Consult a clinician if you take prescription medication regularly.
Not a replacement for prescribed therapy — In rheumatoid arthritis, IBD, or asthma, Boswellia should be adjunctive only — stopping DMARDs, mesalazine, or inhaled corticosteroids in favour of it risks serious disease flares.
Avoid in pregnancy and before surgery — Traditional use flags it as potentially uterine-stimulating, and safety data in pregnancy are absent. Its possible antiplatelet activity also warrants stopping it around 1-2 weeks before planned surgery.
⚕️ Medical Notice: All health information on ClearOnHealth is carefully researched, reviewed, and fact-checked to ensure accuracy. It is intended for general informational purposes only and does not replace the advice of a qualified healthcare professional. Always consult your doctor before starting any supplement, especially if you take medication or have a health condition.

Was this information helpful?

Flag an issue:

💊 More Supplements

🩺 Related Health Topics

Search another topic

Supplements and health topics — one search box